FDA Physician Survey Would Collect Info On Risk Communications
This article was originally published in The Pink Sheet Daily
Executive Summary
Proposed survey seeks to understand when and how physicians like to receive risk information about drug products.
You may also be interested in...
Drug Safety Bulletin Being Considered By FDA
The effort would be overseen by new Associate Center Director for Safety Policy & Communication Paul Seligman.
With Winrevair Approved, Merck Has A Chance To Execute On CV Strategy
The activin signaling inhibitor sotatercept was approved by the US FDA for pulmonary arterial hypertension.
CinFina Pushes Early Work In Obesity In Hopes Of A Deal
Emerging Company Profile: CinFina is advancing two novel mechanisms of action in obesity as monotherapies and in combination with GLP-1s.